Cargando…

MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS

MicroRNAs have been reported to play a vital role in diverse biological processes and tumorigenesis. MicroRNA-19b-5p has been observed to be downregulated in other cancers, but the function of microRNA-19b-5p in human nasopharyngeal carcinoma has not been well investigated. In our study, these resul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuan, Zhao, Yulin, Liu, Lei, Su, Hongxia, Dong, Dong, Wang, Jia, Zhang, Yaqian, Chen, Qi, Li, Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149031/ https://www.ncbi.nlm.nih.gov/pubmed/30231694 http://dx.doi.org/10.1177/1533033818793652

Ejemplares similares

Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis
por: Zhang, Xian, et al.
Publicado: (2015)

microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells
por: Cui, Zheqing, et al.
Publicado: (2019)

HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma
por: Li, Haineng, et al.
Publicado: (2021)

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
por: Konoshenko, Maria, et al.
Publicado: (2022)

MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression
por: Liang, Wei, et al.
Publicado: (2019)

MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2
por: Fan, Chuannan, et al.
Publicado: (2016)

MicroRNA-mediated regulation of KRAS in cancer
por: Kim, Minlee, et al.
Publicado: (2014)

KRAS-associated microRNAs in colorectal cancer
por: Ibrahim, Hamizah, et al.
Publicado: (2020)

MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin
por: Qian, Yan, et al.
Publicado: (2020)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

MicroRNAs in nasopharyngeal carcinoma
por: Bruce, Jeff P., et al.
Publicado: (2014)

[Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways
por: Kang, Kang, et al.
Publicado: (2023)

MicroRNA-432 Suppresses Invasion and Migration via E2F3 in Nasopharyngeal Carcinoma
por: Wang, Tingting, et al.
Publicado: (2019)

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

KRAS induces lung tumorigenesis through microRNAs modulation
por: Shi, Lei, et al.
Publicado: (2018)

MicroRNA‑224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
por: Geng, Shuo, et al.
Publicado: (2016)

MicroRNA-223-5p suppresses the progression of nasopharyngeal carcinoma by targeting DCLK1
por: Zhang, Zhixuan, et al.
Publicado: (2021)

MicroRNA-149* suppresses hepatic inflammatory response through antagonizing STAT3 signaling pathway
por: Zhang, Qiqi, et al.
Publicado: (2017)

The role of microRNAs in nasopharyngeal carcinoma
por: Tan, Gongjun, et al.
Publicado: (2014)

MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
por: Vanas, Vanita, et al.
Publicado: (2016)

Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in Nasopharyngeal Carcinoma via activation of NF-κB pathway
por: Chen, Shu-Peng, et al.
Publicado: (2014)

Autophagy inhibition impairs the epithelial-mesenchymal transition and enhances cisplatin sensitivity in nasopharyngeal carcinoma
por: Su, Zhongwu, et al.
Publicado: (2017)

MicroRNA-212 suppresses cell proliferation in nasopharyngeal carcinoma by targeting ELF3
por: Kang, Yaojie, et al.
Publicado: (2020)

The anticancer effect of EGFR‐targeting artificial microRNA controlled by SLPI promoter in nasopharyngeal carcinoma
por: Dong, Feilin, et al.
Publicado: (2022)

Epstein-Barr Virus_Encoded LMP1 Upregulates MicroRNA-21 to Promote the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin-Induced Apoptosis by Suppressing PDCD4 and Fas-L
por: Yang, Guang-Da, et al.
Publicado: (2013)

MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
por: Zhou, Xiang, et al.
Publicado: (2018)

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways
por: Liu, Xuerong, et al.
Publicado: (2022)

Role of eIF3a in regulating cisplatin sensitivity and nucleotide excision repair of nasopharyngeal carcinomas
por: Liu, Ran-Yi, et al.
Publicado: (2011)

CRISPR-Induced Loss of Connexin 43 Expression Sensitizes KRAS Mutant Cells to Cisplatin
por: Martin, Stephen, et al.
Publicado: (2022)

Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
por: Wang, Sumei, et al.
Publicado: (2019)

MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway
por: Zhao, Yan, et al.
Publicado: (2018)

Osthole sensitizes with radiotherapy to suppress tumorigenesis of human nasopharyngeal carcinoma in vitro and in vivo
por: Peng, Lin, et al.
Publicado: (2018)

Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity
por: VOON, YEE-LIN, et al.
Publicado: (2015)

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
por: Okamura, Shunsuke, et al.
Publicado: (2021)

Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition
por: Bao, Ying, et al.
Publicado: (2020)

Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients
por: Jin, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h6nak2sf1p412ln0g442tb48cd